We are live on ! Find out more
TI

Turner Investments Portfolio holdings

AUM $134K
1-Year Est. Return 49.03%
This Fund
S&P 500
This Quarter Est. Return
+12.34%
1 Year Est. Return
-49.03%
3 Year Est. Return
+6.36%
5 Year Est. Return
+75.79%
10 Year Est. Return
AUM
$483M
AUM Growth
-$11M
Cap. Flow
-$43.3M
Cap. Flow %
-8.96%
Top 10 Hldgs %
17.29%
Holding
311
New
73
Increased
63
Reduced
66
Closed
97

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$6.13M
2
NVS icon
Novartis
NVS
+$5.19M
3
WYNN icon
Wynn Resorts
WYNN
+$4.77M
4
APTV icon
Aptiv
APTV
+$4.44M
5
WP
Worldpay, Inc.
WP
+$4.38M

Sector Composition

Rank Sector Weight
1 Healthcare 36.11%
2 Technology 20.43%
3 Financials 7.74%
4 Consumer Discretionary 7.72%
5 Industrials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
51
Regeneron Pharmaceuticals
REGN
$78.9B
$3.41M 0.71%
6,290
-4,820
-43% -$2.61M
GILD icon
52
Gilead Sciences
GILD
$163B
$3.4M 0.7%
33,650
+8,700
+35% +$905K
MBLY
53
DELISTED
Mobileye N.V.
MBLY
$3.39M 0.7%
80,100
-9,320
-10% -$417K
MARK
54
DELISTED
Remark Holdings, Inc.
MARK
$3.26M 0.67%
62,963
-10,538
-14% -$468K
PBH icon
55
Prestige Consumer Healthcare
PBH
$2.51B
$3.24M 0.67%
63,000
+16,650
+36% +$827K
FANG icon
56
Diamondback Energy
FANG
$52.7B
$3.19M 0.66%
47,610
+35,610
+297% +$2.65M
WWAV
57
DELISTED
The WhiteWave Foods Company
WWAV
$3.15M 0.65%
80,910
-43,300
-35% -$1.75M
BIIB icon
58
Biogen
BIIB
$30.5B
$2.98M 0.62%
9,715
+9,565
+6,377% +$2.75M
ARMK icon
59
Aramark
ARMK
$14.9B
$2.97M 0.61%
+127,669
New +$2.92M
AVDL
60
DELISTED
Avadel Pharmaceuticals
AVDL
$2.92M 0.6%
239,308
+104,340
+77% +$1.63M
CNMD icon
61
CONMED
CNMD
$1.49B
$2.85M 0.59%
+64,632
New +$2.8M
IPHI
62
DELISTED
INPHI CORPORATION
IPHI
$2.84M 0.59%
105,000
HRTX icon
63
Heron Therapeutics
HRTX
$95.4M
$2.83M 0.59%
106,080
+17,470
+20% +$467K
AYI icon
64
Acuity Brands
AYI
$10.7B
$2.81M 0.58%
12,000
+11,000
+1,100% +$2.39M
SPSC icon
65
SPS Commerce
SPSC
$2.64B
$2.7M 0.56%
77,000
-31,000
-29% -$1.13M
OA
66
DELISTED
Orbital ATK, Inc.
OA
$2.68M 0.55%
+30,000
New +$2.52M
EBS icon
67
Emergent Biosolutions
EBS
$389M
$2.61M 0.54%
65,220
EGRX
68
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$2.35M 0.49%
+26,500
New +$2.09M
ADBE icon
69
Adobe
ADBE
$102B
$2.22M 0.46%
23,610
-33,810
-59% -$3.04M
LGND icon
70
Ligand Pharmaceuticals
LGND
$6.06B
$2.17M 0.45%
32,060
+24,045
+300% +$1.48M
MXL icon
71
MaxLinear
MXL
$6.29B
$2.14M 0.44%
145,000
+110,000
+314% +$1.66M
CBM
72
DELISTED
Cambrex Corporation
CBM
$2.12M 0.44%
+45,000
New +$2.16M
OCRX
73
DELISTED
Ocera Therapeutics, Inc.
OCRX
$2.1M 0.43%
673,487
+152,210
+29% +$520K
BA icon
74
Boeing
BA
$190B
$2.08M 0.43%
+14,400
New +$2.07M
STJ
75
DELISTED
St Jude Medical
STJ
$2.04M 0.42%
33,010
-2,710
-8% -$171K

Similar funds

Turner Investments's Q4 2015 Portfolio in Review

As of Q4 2015, Turner Investments held 311 positions worth $483M, down 2.2% from $494M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Turner Investments withdrew a net $43.3M in Q4 2015, closing 97 positions and reducing 66 holdings. Its most notable exit was Advance Auto Parts, an estimated $5.92M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

Against the trend, Turner Investments opened a new position in Intuitive Surgical worth $6.63M.

  • Turner Investments's largest Q4 2015 buy was Intuitive Surgical: 109,170 shares worth $6.63M.
  • Turner Investments added most to Novartis in Q4 2015, an estimated $5.19M increase.
  • Turner Investments's biggest Q4 2015 reduction was NXP Semiconductors, cutting an estimated $7.29M.
  • Turner Investments fully exited Advance Auto Parts in Q4 2015, selling an estimated $5.92M.
  • Turner Investments's ten largest holdings make up 17% of its $483M portfolio in Q4 2015.
  • Turner Investments opened 73 new positions and closed 97 in Q4 2015.
  • Turner Investments's portfolio value fell 2.2% quarter-over-quarter to $483M.

Based on Turner Investments's 13F filing for Q4 2015, filed 9 Feb 2016.